Evaluating Perioperative Dexamethasone and the Risk of Bleeding in Tonsillectomy

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

314 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-07-31

Study Completion Date

2011-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Tonsillectomy (removal of the tonsils) is a very common surgery in children. Bleeding after tonsillectomy is one of the risks of this surgery and can be more dangerous in children since they have less blood volume than adults. In order to improve recovery after tonsillectomy, steroids (medication that is a strong anti-inflammatory) are often given during the surgery. Recently, a study showed steroids given at the time of tonsillectomy increase the risk of bleeding significantly over children who did not receive steroids. This finding has raised concerns in the Ear, Nose, and Throat (ENT) community since most ENT's use steroids during tonsillectomy in children. The investigators look to explore this question further.

To answer the question of whether perioperative steroid administration significantly affects the rate of post-tonsillectomy bleeding, the investigators propose to test the following hypotheses in a prospective, randomized, blinded placebo-controlled trial: dexamethasone does not cause an increase in post-operative bleeding rate in tonsillectomy.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effect of Dexamethasone Dosing on Post-tonsillectomy Hemorrhage

NCT02228135

Tonsillectomy Adenotonsillectomy

COMPLETED

Dexamethasone and Postoperative Bleeding Following Tonsillectomy in Children

NCT04188431

Pain, Postoperative Tonsillar Bleeding Postoperative Nausea and Vomiting

TERMINATED PHASE4

Post-operative Course of Dexamethasone to Reduce Tonsillectomy Morbidity

NCT04879823

Adenotonsillectomy Analgesia Surgery

TERMINATED PHASE3

Perioperative Tonsillectomy Protocol Development

NCT03323047

Tonsillitis

UNKNOWN PHASE4

Dexamethasone and Post-tonsillectomy Pain in Children

NCT02793011

Pediatric Post-tonsillectomy Pain

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Detailed description is entered above

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-operative Hemorrhage

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Saline

Placebo is described in chart

Group Type PLACEBO_COMPARATOR

Dexamethasone

Intervention Type DRUG

0.5mg/kg (max dose 20mg)

Dexamethasone

Dexamethasone is described in chart

Group Type EXPERIMENTAL

Dexamethasone

Intervention Type DRUG

0.5mg/kg (max dose 20mg)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dexamethasone

0.5mg/kg (max dose 20mg)

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Decadron

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients ages 3 to 18 undergoing tonsillectomy or adenotonsillectomy by electrocautery alone for the indication of sleep disordered breathing or infectious tonsillitis.
* Patients with complex medical conditions or craniofacial abnormalities will be included.
* Informed consent and child assent are required for enrollment.
* Eligibility will be determined by the principal investigator, associate investigator or research nurse.

Exclusion Criteria

* Subjects with a known personal or family history of any bleeding disorder will be excluded.
* Subjects currently on oral corticosteroids for other medical conditions or have recently taken any oral corticosteroid within two weeks of surgery.
* Patients with tonsillectomy performed using a cold knife technique, microdebrider, coblation or plasma knife due to surgeon or parent preference.
* Where appropriate subjects who do not have informed consent or child assent signed will be excluded
* Children less than three years old will be excluded due to the fact the majority of these children at the collaborating centers have an adenotonsillectomy using the microdebrider for pain control purposes.

Minimum Eligible Age

3 Years

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No